Position history for BlackRock, Inc.'s holdings in TREVI THERAPEUTICS INC
BlackRock, Inc. holds 10.1M shares of TRVI (TREVI THERAPEUTICS INC), worth $126.8M as of 2025-Q4. The position was increased (++2.3% shares). TRVI represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$126.8M
Current Shares
10.1M
Total Value Change
+$110.6M
Total Shares Change
+6.2M
Other major holders of TRVI: FMR LLC, VANGUARD GROUP INC, MARSHALL WACE, LLP, TPG Group Holdings (SBS) Advisors, Inc.
Increased |
| 10.1M |
+2.3% |
| $126.8M |
| 0.0% |
| $12.56 |
31 |
| 2025-Q3 | Increased | 9.9M | +20.7% | $90.6M | 0.0% | $8.95 | 36 |
| 2025-Q2 | Increased | 8.2M | +54.5% | $44.9M | 0.0% | $5.62 | 41 |
| 2025-Q1 | Increased | 5.3M | +35.2% | $33.4M | 0.0% | $6.50 | 37 |
| 2024-Q4 | New | 3.9M | - | $16.2M | 0.0% | $4.10 | 39 |